ITCI - Intra-Cellular Therapies GAAP EPS of -$0.25 beats by $0.34 revenue of $126.17M beats by $6.94M
2023-11-02 07:45:01 ET
More on Intra-Cellular Therapies
- Intra-Cellular Therapies: Caplyta's Rise And A Promising Pipeline
- Intra-Cellular Therapies Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Intra-Cellular Therapies
- Historical earnings data for Intra-Cellular Therapies
- Financial information for Intra-Cellular Therapies
For further details see:
Intra-Cellular Therapies GAAP EPS of -$0.25 beats by $0.34, revenue of $126.17M beats by $6.94M